Ketone Body Metabolism and Its Effects on Brain Function
The brain normally depends on glucose for energy. During fasting, prolonged exercise, or a very low-carbohydrate diet, glucose supply falls. The liver then produces ketone bodies as an alternative fuel. These molecules cross the blood–brain barrier and support neuronal energy needs.
The three main ketone bodies are acetoacetate, β-hydroxybutyrate, and acetone. Hepatocytes form them from fatty acids through β-oxidation. Acetyl-CoA builds up when the citric acid cycle slows. Two acetyl-CoA molecules then condense to form acetoacetyl-CoA. HMG-CoA synthase converts this intermediate into HMG-CoA. HMG-CoA lyase splits HMG-CoA into acetoacetate. β-Hydroxybutyrate dehydrogenase reduces most of the acetoacetate to β-hydroxybutyrate. A small fraction of acetoacetate breaks down spontaneously into acetone, which the lungs exhale.
The liver cannot use the ketones it makes, because it lacks succinyl-CoA:acetoacetate CoA transferase. Extrahepatic tissues, including the brain, express this enzyme. Inside neurons and astrocytes, β-hydroxybutyrate is oxidized back to acetoacetate. Acetoacetate is then activated to acetoacetyl-CoA and cleaved into two acetyl-CoA molecules. These enter the citric acid cycle and drive ATP production through oxidative phosphorylation.
Ketone use changes brain energy handling in several ways. First, ketones yield more ATP per unit of oxygen than glucose, so they improve metabolic efficiency. Second, they spare glucose for cells that still need it. Third, β-hydroxybutyrate raises the NAD+/NADH ratio less sharply than glucose oxidation in some pathways, which can lower oxidative stress. As a result, neurons often maintain membrane potential and synaptic transmission even when glucose is limited.
Ketones also affect signaling, not only fuel supply. β-hydroxybutyrate inhibits class I histone deacetylases. This shift can increase expression of genes linked to stress resistance and brain-derived neurotrophic factor. In addition, ketones can open ATP-sensitive potassium channels and dampen excessive neuronal firing. That effect helps explain the anticonvulsant action seen in ketogenic diets used for drug-resistant epilepsy.
Clinical and experimental work supports several brain effects. In epilepsy, a sustained rise in blood ketones often reduces seizure frequency. In aging and neurodegenerative models, ketone supplementation has been linked to better mitochondrial function and, in some studies, modest gains in cognitive scores. After brain injury or stroke, ketones may support cells in the penumbra by bypassing damaged glycolytic steps. These findings are promising, but they do not mean ketones reverse established disease.
Ketone metabolism is not risk-free. Uncontrolled production, as in diabetic ketoacidosis, lowers blood pH and can impair consciousness. Physiological ketosis from fasting or a supervised ketogenic diet stays far below that range. People with certain metabolic disorders, pregnancy, or unstable diabetes should not raise ketones without medical advice.
In short, the liver converts excess fatty-acid acetyl-CoA into ketone bodies. The brain oxidizes those ketones to acetyl-CoA and generates ATP. Beyond fuel, ketones influence gene expression, excitability, and oxidative balance. These actions explain their role in fasting, epilepsy care, and emerging research on brain resilience.
